YDS Pharmatech Launches Data Partner Program with N1 Life, Leveraging Proprietary Peptide Experimental Data to co-develop Generative AI-driven peptide design platform
Accuredit Therapeutics and N1 Life Form a Joint Venture Named 'Napoltec', Dedicated to the Development of Therapeutic Drug Delivery Systems and Pressing Ahead Clinical Translation